Engineered Escherichia coli Achieves Record High-Titer Biosynthesis of Antibiotic Angustmycin A
Researchers engineered an Escherichia coli cell factory capable of de novo Angustmycin A biosynthesis, reaching a record titer of approximately ...
Researchers engineered an Escherichia coli cell factory capable of de novo Angustmycin A biosynthesis, reaching a record titer of approximately ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.